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Combined anterior pituitary function test using
CRH, GRH, LH-RH, TRH and vasopressin in
patients with non-functioning pituitary
tumors.∗
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Kageyama, Takashi Ogasa, and Zensuke Ota
Abstract
We examined 8 normal subjects and 16 patients with non-functioning pituitary tumors with a
combined anterior pituitary test to evaluate the clinical usefulness of the test. Diagnoses included
9 of chromophobe adenoma, 3 of craniopharyngioma, 2 of Rathke’s cleft cyst, and 1 each of in-
trasellar cyst and tuberculum sella meningioma. All subjects received hypothalamic releasing hor-
mones: 1 micrograms/kg corticotropin releasing hormone (CRH), 1 micrograms/kg growth hor-
mone releasing hormone (GRH), 500 micrograms thyrotropin-releasing hormone (TRH), 100 mi-
crograms luteinizing hormone releasing hormone (LH-RH), and a relatively small dose (5 mU/kg)
of lysine vasopressin (LVP). In the normal subjects, the addition of LVP potentiated the secretion
of adenocorticotropic hormone (ACTH) induced by CRH, but had no significant effect on the se-
cretion of other anterior pituitary hormones. In the combined test with 5 releasing hormones, the
plasma ACTH and cortisol responses were not impaired in the majority of the patients before pitu-
itary surgery. Serum thyroid-stimulating hormone (TSH), prolactin (PRL) and follicle-stimulating
hormone (FSH) responses were not impaired in 82%, 70% and 67% of the patients, respectively,
while the serum LH and GH responses were impaired in 67% and 73% of the patients, respectively.
Following pituitary surgery, responses of these hormones to combined testing were similarly im-
paired in more than 75% of the patients. These results indicate that plasma ACTH, cortisol and
serum TSH responses are fairly good before pituitary surgery but are impaired significantly after
surgery. No subjects experienced any serious adverse effects related to the testing. These results
suggest that combined testing with hypothalamic hormones is a convenient and useful method for
evaluating pituitary function.
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